首页 >
法规速递
-
国家药监局药审中心关于发布《疫苗临床试验不良事件分级标准指导原则（修订版）》的通告（2025年第49号）-2025/12/5
2025-12-08查看详情 > -
国家药监局关于化学药品和生物制品全面实施药品电子通用技术文档申报的公告（2026年第8号）-2026/1/15
2026-01-16查看详情 > -
Page: Good pharmacovigilance practices (GVP)-2026/2/16
2026-02-26查看详情 > -
Document: Minutes – Ad hoc Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 5 March 2026-2026/3/24
2026-03-25查看详情 > -
Document: Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2026-2026/4/29
2026-04-30查看详情 > -
FDA and Industry Actions on Premarket Notification (510(k)) Submissions: Effect on FDA Review Clock and Goals(Final)-2022/10/3
2022-11-14查看详情 > -
国家药监局药审中心关于发布《抗肿瘤抗体偶联药物临床研发技术指导原则》的通告（2023年第25号）-2023/4/7
2023-04-10查看详情 > -
关于公开征求《化学药品注射剂配伍稳定性药学研究技术指导原则（征求意见稿）》意见的通知-2023/10/07
2023-10-08查看详情 > -
Document: EudraVigilance - EVWEB user manual-2025/1/7
2025-01-08查看详情 > -
Document: Agenda - EMA Veterinary Innovation Day - March 2025-2025/2/13
2025-02-14查看详情 >
